dipyrone and Anemia, Hypoplastic

dipyrone has been researched along with Anemia, Hypoplastic in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19902 (25.00)18.7374
1990's0 (0.00)18.2507
2000's6 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aslan, D; Cetin, M; Ozyürek, E; Yetgin, S1
Beau, P; Blanchet, E; Frat, JP1
Centkowski, P; Maj, S1
Cavalcanti, AB; Hamerschlak, N1
Moorman, J1
Benseñor, IM1
Doll, R; Lunde, PK; Moeschlin, S1

Reviews

1 review(s) available for dipyrone and Anemia, Hypoplastic

ArticleYear
Neutropenia, agranulocytosis and dipyrone.
    Sao Paulo medical journal = Revista paulista de medicina, 2005, Sep-01, Volume: 123, Issue:5

    Topics: Agranulocytosis; Anemia, Aplastic; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Dipyrone; Humans; Incidence; Latin America; Neutropenia; Pilot Projects

2005

Other Studies

7 other study(ies) available for dipyrone and Anemia, Hypoplastic

ArticleYear
Metamizole sodium-induced severe aplastic anemia and its recovery with a short-course steroid therapy.
    Pediatric hematology and oncology, 2004, Volume: 21, Issue:4

    Topics: Adolescent; Anemia, Aplastic; Anti-Inflammatory Agents, Non-Steroidal; Dipyrone; Female; Glucocorticoids; Humans; Methylprednisolone; Steroids; Urinary Tract Infections

2004
[Bone marrow aplasia following dipyrone treatment in a patient with Crohn's disease receiving long-term methotrexate].
    Gastroenterologie clinique et biologique, 2004, Volume: 28, Issue:5

    Topics: Adult; Anemia, Aplastic; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Dipyrone; Female; Humans; Immunosuppressive Agents; Methotrexate; Time Factors

2004
A prospective study of the incidence of agranulocytosis and aplastic anemia associated with the oral use of metamizole sodium in Poland.
    Medical science monitor : international medical journal of experimental and clinical research, 2004, Volume: 10, Issue:9

    Topics: Administration, Oral; Agranulocytosis; Anemia, Aplastic; Anti-Inflammatory Agents, Non-Steroidal; Dipyrone; Humans; Nonprescription Drugs; Poland; Prospective Studies

2004
Dipyrone (metamizole) use in the United States: a lethal tango?
    Southern medical journal, 2006, Volume: 99, Issue:9

    Topics: Agranulocytosis; Anemia, Aplastic; Anti-Inflammatory Agents, Non-Steroidal; Dipyrone; Hispanic or Latino; Humans; Latin America

2006
To use or not to use dipyrone? Or maybe, Central Station versus ER? That is the question.
    Sao Paulo medical journal = Revista paulista de medicina, 2001, Nov-01, Volume: 119, Issue:6

    Topics: Agranulocytosis; Anemia, Aplastic; Anti-Inflammatory Agents, Non-Steroidal; Dipyrone; Evidence-Based Medicine; Humans; Mass Media

2001
Analgesics, agranulocytosis, and aplastic anaemia.
    Lancet (London, England), 1987, Jan-10, Volume: 1, Issue:8524

    Topics: Agranulocytosis; Analgesics; Anemia, Aplastic; Dipyrone; Humans; Risk

1987
Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study.
    JAMA, 1986, Oct-03, Volume: 256, Issue:13

    Topics: Acetaminophen; Adult; Aged; Agranulocytosis; Aminopyrine; Analgesics; Anemia, Aplastic; Antipyrine; Dipyrone; Europe; Humans; Israel; Middle Aged; Phenylbutazone; Risk; Salicylates

1986